jRCT2031240252招募中不适用
Ferinject Intravenous Injection 500mg General Use Result Survey
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- No limit 至 No limit（—）
- 性别
- All
入选标准
- •Patients with iron deficiency anaemia who were treated Ferinject.
排除标准
- 未提供
结局指标
主要结局
-
Adverse event
次要结局
未报告次要终点
研究者
相似试验
尚未招募
Unknown
Fetroja for Intravenous Drip Infusion Regular Drug Use-results SurveyInfectionsJPRN-UMIN000053151Shionogi & Co., Ltd.200
尚未招募
不适用
Treatment for aqueous deficiency dry eyesCTRI/2020/12/029574V Prasad Eye Institute
撤回
不适用
Pilot feasibility study of Ferinject® in patients with esophageal cancer100020861001799010017998anemiaNL-OMON37387Academisch Medisch Centrum20
招募中
不适用
HEMLIBRA Subcutaneous injection General Drug Use Surveillance(in Hemophilia A with Inhibitors).Hemophilia AJPRN-UMIN000032515Chugai Pharmaceutical Co. Ltd.100
进行中（未招募）
不适用
Intravenous ferric carboxymaltose (Ferinject®) with or without Erythropoietin for the correction of preoperative anaemia in patients undergoing orthopaedic surgery•To evaluate the effect of the administration of ferric carboxymaltose (Ferinject®) with or without erythropoietin vs. no treatment (standard therapy) on the preoperative anaemia status in patients undergoing orthopaedic surgery •To gain informations for the design of a possible follow-up study•.•To evaluate the tolerability and safety of Ferinject®EUCTR2009-015799-92-ATniversitätspital Zürich Anästhesie75